BioSpace News Archive

Pfizer indicated yesterday that its Phase III clinical trial of 44,000 volunteers now needs fewer than 2,000 people to be fully enrolled.

The report showed that in some cases, people who have recovered from the virus continued to exhibit significant cognitive deficits.

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the third quarter of 2020 on Thursday, November 5, 2020 a

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today a distribution agreement with Sofregen Medical Inc. for its Silk Voice Injectable Implant.

Oxford Nanopore announces multiple releases that expand and improve its sequencing technology offering in human genomics, at ASHG 2020.

Diaceutics PLC, (AIM: DXRX), today announces the launch of DXRX – The Diagnostic Network® which has been designed to accelerate the end-to-end development and commercialization of precision medicine diagnostics by reducing time to peak biomarker test adoption for cancer testing from years to months.

As part of its commitment to community engagement and organizational capacity building, the National Organization for Rare Disorders’ RareLaunch® training program will host two days of free workshops to take place in December, funded in part through a grant from the Chan Zuckerberg Initiative Donor-Advised Fund, an advised fund of Silicon Valley Community Foundation.

In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “As the resurgence of COVID-19 activity continues in Canada , we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how i

The Foundation has posted the 55-page report, along with a complete transcript of the meeting, the more than 300 email comments that were submitted and a link to the official video recording on its website.

As part of its continued mission to connect the global healthcare community with clinically relevant information and education that improves patient care, HMP Global, a leading healthcare event and education company, today announced a significant expansion into the field of women’s oncology.